Literature DB >> 19925749

Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.

Boaz Levy1, Roger D Weiss.   

Abstract

OBJECTIVE: Recent studies have reported greater neurocognitive impairment in euthymic bipolar disorder patients with a history of psychosis relative to patients without such a history. To further explore the relation between psychosis and cognitive dysfunction in bipolar disorder, the current study examined the cognitive functioning of patients during early remission from a discrete episode of mood disturbance. The study aimed to determine whether the presence of psychosis during inpatient hospitalization was associated with greater cognitive impairment at the time of hospital discharge.
METHOD: Fifty-nine inpatients who met DSM-IV criteria for bipolar disorder (24 admitted with psychosis, 35 admitted without psychosis), ages 18-59 years, completed a neuropsychological battery and mood measures 24-48 hours before discharge. The cognitive battery included standardized tests of IQ, attention and working memory, visual memory, verbal memory, and executive functioning.
RESULTS: A multivariate analysis of variance detected group differences on measures of verbal memory (P < .001) and executive functioning (P < .003), using mood measures and previous number of psychiatric admissions as covariates. Post hoc analysis of between-subjects effects revealed significantly poorer performance on the California Verbal Learning Test-Second Edition, logical memory subtest from Wechsler Memory Scale-Revised, Stroop Word/Color Interference test, and the Wisconsin Card Sorting Test for patients who were admitted to the hospital with psychosis. These results remained significant after matching the groups for past psychosis, with the exception of the logical memory subtest.
CONCLUSIONS: The results of this study indicate that patients with bipolar disorder who were admitted to the hospital due to psychosis exhibited significantly more severe cognitive impairment at the time of discharge than patients admitted for an acute mood disturbance without psychosis. These findings may be important for improving discharge planning and the development of more effective outpatient services. Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19925749      PMCID: PMC3143061          DOI: 10.4088/JCP.08m04663yel

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  23 in total

1.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

2.  Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders.

Authors:  M Albus; W Hubmann; C Wahlheim; N Sobizack; U Franz; F Mohr
Journal:  Acta Psychiatr Scand       Date:  1996-08       Impact factor: 6.392

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

4.  The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder.

Authors:  Stuart Donaldson; Laura H Goldstein; Sabine Landau; Vanessa Raymont; Sophia Frangou
Journal:  J Clin Psychiatry       Date:  2003-01       Impact factor: 4.384

5.  Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features.

Authors:  D J Miklowitz
Journal:  J Nerv Ment Dis       Date:  1992-11       Impact factor: 2.254

6.  Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.

Authors:  Lori L Altshuler; Joseph Ventura; Wilfred G van Gorp; Michael F Green; David C Theberge; Jim Mintz
Journal:  Biol Psychiatry       Date:  2004-10-15       Impact factor: 13.382

7.  Neurocognitive impairment in bipolar patients with and without history of psychosis.

Authors:  Anabel Martinez-Aran; Carla Torrent; Rafael Tabares-Seisdedos; Manel Salamero; Claire Daban; Vicente Balanza-Martinez; Jose Sanchez-Moreno; Jose Manuel Goikolea; Antoni Benabarre; Francesc Colom; Eduard Vieta
Journal:  J Clin Psychiatry       Date:  2008-02       Impact factor: 4.384

8.  Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis.

Authors:  David C Glahn; Carrie E Bearden; Sibel Cakir; Jennifer A Barrett; Pablo Najt; E Serap Monkul; Natalie Maples; Dawn I Velligan; Jair C Soares
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

9.  Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

Authors:  Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.

Authors:  Emre Bora; Simavi Vahip; Fisun Akdeniz; Ali Saffet Gonul; Ayse Eryavuz; Melise Ogut; Muge Alkan
Journal:  Bipolar Disord       Date:  2007-08       Impact factor: 6.744

View more
  10 in total

Review 1.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

2.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

3.  Memory in early onset bipolar disorder and attention-deficit/hyperactivity disorder: similarities and differences.

Authors:  Anne H Udal; Bjørg Oygarden; Jens Egeland; Ulrik F Malt; Berit Groholt
Journal:  J Abnorm Child Psychol       Date:  2012-10

4.  Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder.

Authors:  Yu-Ming Liu; Shang-Ying Tsai; David E Fleck; Stephen M Strakowski
Journal:  Psychiatry Res       Date:  2011-06-17       Impact factor: 3.222

5.  The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.

Authors:  Boaz Levy; Anna Marie Medina; Emily Manove; Roger D Weiss
Journal:  J Psychiatr Res       Date:  2011-02-08       Impact factor: 4.791

Review 6.  Neurocognitive impairment and evidence-based treatment options in Bipolar disorder.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2020-09-23       Impact factor: 3.455

7.  Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study.

Authors:  Boaz Levy; Anna Marie Medina; Roger D Weiss
Journal:  Compr Psychiatry       Date:  2013-01-26       Impact factor: 3.735

Review 8.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

9.  Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode.

Authors:  Boaz Levy; Emily Manove; Roger D Weiss
Journal:  Ann Clin Psychiatry       Date:  2012-05       Impact factor: 1.567

10.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.